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Tissue-engineered meniscus regeneration is a very promising treatment strategy for meniscus lesions.
However, generating the scaffold presents a huge challenge for meniscus engineering as this has to meet
particular biomechanical and biocompatibility requirements. In this study, we utilized acellular meniscus
extracellular matrix (AMECM) and demineralized cancellous bone (DCB) to construct three different
types of three-dimensional porous meniscus scaffold: AMECM, DCB, and AMECM/DCB, respectively. We
tested the scaffolds' physicochemical characteristics and observed their interactions with meniscus
ﬁbrochondrocytes to evaluate their cytocompatibility. We implanted the three different types of scaffold
into the medial knee menisci of New Zealand rabbits that had undergone total meniscectomy; negative
control rabbits received no implants. The reconstructed menisci and corresponding femoral condyle and
tibial plateau cartilage were all evaluated at 3 and 6 months (n ¼ 8). The in vitro study demonstrated that
the AMECM/DCB scaffold had the most suitable biomechanical properties, as this produced the greatest
compressive and tensile strength scores. The AMECM/DCB and AMECM scaffolds facilitated ﬁbrochon-
drocyte proliferation and the secretion of collagen and glycosaminoglycans (GAGs) more effectively than
did the DCB scaffold. The in vivo experiments demonstrated that both the AMECM/DCB and DCB groups
had generated neomeniscus at both 3 and 6 months post-implantation, but there was no obvious
meniscus regeneration in the AMECM or control groups, so the neomeniscus analysis could not perform
on AMECM and control group. At both 3 and 6 months, histological scores were better for regenerated
menisci in the AMECM/DCB than in the DCB group, and signiﬁcantly better for articular cartilage in the
AMECM/DCB group compared with the other three groups. Knee MRI scores (Whole-Organ Magnetic
Resonance Imaging Scores (WORMS)) were better in the AMECM/DCB group than in the other three
groups at both 3 and 6 months. At both 3 and 6 months, RT-PCR demonstrated that aggrecan, Sox9, and
collagen II content was signiﬁcantly higher, and mechanical testing demonstrated greater tensile
strength, in the AMECM/DCB group neomenisci compared with the DCB group.
© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).lear_ann@163.com (S. Liu),
. Guo), 591685142@qq.com
mingxueplagh@hotmail.com
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Ltd. This is an open access article u1. Introduction
The knee meniscus is the crescent-shaped connective tissue
between the femoral condyle and tibial plateau. It distributes the
body weight, absorbs shock, reduces friction between the tibial
surface and femoral condyle, and stabilizes the joint during ﬂexion
and extension [1]. Damage to the meniscus is among the most
common injuries to the knee joint, often resulting from an impact
during sport, or simply due to joint degeneration. Suture repair isnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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meniscus, because only the outer part of the meniscus is vascu-
larized, that can make the meniscus periphery self-healing avail-
able [2]. However, for serious meniscus damage, partial or total
meniscectomy is the most common treatment strategy, although
this can hasten the degeneration of articular cartilage and induce
osteoarthritis [3]. Meniscal allograft transplantation can reduce
pain and enhance function in the short term. However, the long-
term efﬁcacy of meniscal allografts is uncertain [4].
Tissue engineering has been proposed as a promising therapy
for meniscal regeneration [5]. Recently, a number of studies have
investigated the possibility of using synthetic scaffolds to
completely replace the meniscus [6]. Chang Lee and co-workers [7]
used a three-dimensional (3D) printed biomaterial scaffold that
releases two recombinant proteins in a spatially and temporally
controlled manner to regenerate sheep meniscus. They reported
that the biomaterial scaffold promoted kneemeniscus regeneration
in a large animal model at 3-month follow-up, but the study lacked
longer-term evaluation. Merriam and co-workers [8,9] used a novel
ﬁber-reinforced scaffold to regenerate the meniscus in an ovine
model, and reported that this scaffold can act as a functional
meniscus replacement, while protecting the articular cartilage of
the knee after a total meniscectomy. Because of their excellent
mechanical properties, polymer scaffolds can perform very well in
animal studies in the short term. However, the biocompatibility of
polymers is low compared with natural materials and their long-
term efﬁcacy after the polymer begins to degrade is unknown
[10]. The only natural biological material which has been applied in
patients is collagen meniscus implants (CMI) [10], which is made
from puriﬁed type I collagen derived from bovine Achilles tendon.
After preliminary tests on animals, CMI (Menaﬁex; ReGen Biologics,
Hackensack, NJ, USA) was used in human implants. The results
demonstrated that this scaffold can improve clinical outcomes in
patients with a chronic meniscal injury, and it has subsequently
been used in other clinical studies [11,12]. Currently, the CMI scaf-
fold is distributed by Ivy Sports Medicine (ISM) (formerly ReGen
Biologics). Other natural materials, including silk and bacterial
cellulose gel, have been used to synthesize meniscal scaffolds for
in vitro studies only [13,14].
The microenvironment of the meniscal extracellular matrix
(ECM) plays an important role in regulating cell behavior, and this
may make it a good material for meniscal tissue engineering ap-
plications [15]. The meniscus comprises 72% water, 22% collagen
and 0.8% glycosaminoglycans (GAGs). Type I collagen predominates
(>90% meniscal collagen content) and type II collagen is only found
in the inner meniscal regions [16]. Numerous studies have
demonstrated that ECM-derived protein molecules can have a
positive effect on meniscal tissue regeneration [17e20]. However,
none have focused on meniscal ECM as a scaffold for meniscal
tissue engineering in vivo. In this study, we utilize meniscus ECM to
synthesize a meniscal scaffold and prompt meniscus regeneration
in a rabbit total meniscectomy model.
We also considered the possibility that meniscus ECM-derived
scaffold may not possess the required biomechanical properties
for a complete meniscus implant in vivo, while another natural
material, demineralized cancellous bone (DCB), does have these
properties (natural 3D pore structure, good biocompatibility, and
mechanical strength). DCB has been widely used as a scaffold for
tissue-engineered bone/cartilage regeneration, and may also pro-
vide a good scaffold for tissue-engineered meniscus regeneration
[21].
In this study, we utilized a physical and enzymatic method to
decellularize menisci and generate acellular meniscus extracellular
matrix (AMECM). A modiﬁed version of Urist's protocol was used to
obtain DCB. Additionally, the AMECM and DCB were combined toform an AMECM/DCB scaffold. Therefore, in the present work, we
generated three types of meniscus scaffold: an AMECM scaffold, a
DCB scaffold, and an AMECM/DCB scaffold. We then tested the
physicochemical properties of the three scaffolds, seeded them
with meniscus ﬁbrochondrocytes and implanted each subcutane-
ously into rats to evaluate their biocompatibility. Finally, we
implanted the meniscus scaffolds in a total meniscectomy rabbit
model to evaluate their ability to promote meniscus regeneration.2. Materials and methods
2.1. Scaffold preparation and synthesis
The menisci derived from swine were purchased from a butcher
and washed with electrolyzed oxidizing water, distilled water and
phosphate-buffered saline (PBS; Sigma-Aldrich Ltd., St. Louis, MO,
USA). They were then cut into pieces using scissors, treated with
hydrogen peroxide (Sigma-Aldrich), and washed with distilled
water again. The minced menisci were treated with pepsin (Sigma-
Aldrich) and acetic acid (Sigma-Aldrich), and then homogenized
(Kinematica AG, Lucerne, Switzerland) at low temperature (4 C). A
differential centrifugation method with a high-speed, low-tem-
perature centrifuge (Thermo, Osterode, Germany) was used to
decellularize the menisci as follows: samples were centrifuged
(260 g, 10 min), then the pellet was removed and the supernatant
recentrifuged (2400 g, 10 min), with the pellet was removed again
and the supernatant recentrifuged (6700 g, 30 min); ﬁnally, the
supernatant was removed and the remaining meniscal slurry
retained. The meniscal slurry was placed into crescent-shaped
molds, and freeze-dried to synthesize the AMECM scaffold (Fig. 1A).
Bovine bone was purchased from a butcher and cancellous bone
was removed for use in the protocol. We used a modiﬁed version of
Urist's protocol to prepare DCB as follows: cancellous bone was
immersed in ethanol for 3 h, and then in diethyl ether for 1.5 h
before being washed with distilled water. It was then stirred in HCl
at room temperature for 72 h, washed in distilled water, and
immersed in ethanol for 3 h. Finally, the cancellous bone was
immersed in diethyl ether for 1.5 h, washedwith distilledwater and
freeze-dried to obtain the DCB. Crescent-shaped molds were used
to form the DCB scaffold (Fig. 1A).
We immersed DCB in the meniscal slurry to generate the
AMECM and demineralized bone matrix and, after freeze-drying,
poured the mixture into crescent-shaped molds to form the
AMECM/DCB scaffold (Fig. 1A).
All three types of scaffold were crosslinked using ethyl dimethyl
aminopropyl carbodiimide (0.6 mol/l EDAC; Sigma-Aldrich) and
sterilized using ethylene oxide. The success of decellularizationwas
evaluated by Hoechst staining and a biochemical analysis was
performed to compare the amount of DNA and major ECM com-
ponents (i.e., GAGs and collagen).2.2. Characterization of scaffolds
2.2.1. Biochemical analysis
The TIANamp Genomic DNA kit (TIANamp, Beijing, China) was
used to extract DNA. To quantify DNA in the three different types of
scaffold, the PicoGreen DNA assay kit was used according to the
manufacturer's instructions (Invitrogen, Carlsbad, CA, USA). Total
collagen was measured by the hydroxyproline assay kit according
to the manufacturer's protocol (Nanjing Jiancheng, Jiangsu, China).
GAG content was determined by 1, 9-dimethylmethylene blue
(DMMB) assay using the Tissue GAG Total Content DMMB Color-
imetry kit according to the manufacturer's instructions (Genmed
Scientiﬁc Inc., Shanghai, China).
Fig. 1. A. Flow chart of the preparation of the three different scaffolds. B. Overview of experimental design. (Abbreviations: AMECM - acellular meniscus extracellular matrix; DCB -
demineralized cancellous bone; AMECM/DCB - acellular meniscus extracellular matrix/demineralized cancellous bone).
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The three different scaffolds were ﬁxed in 4% (v/v) para-
formaldehyde solution (Sigma), embedded in parafﬁn, and
sectioned into 7 mm slices. The sections were stained with tolu-
idine blue. Safranin-O was used to stain sulfated proteoglycans
and Sirius Red was used to stain total collagen in the matrix.
For immunohistochemical staining with polyclonal antibodies
against collagen I and II (Abcam, Cambridge, UK), the sections
were deparafﬁnized, hydrated, and permeabilized. Sections
were then washed in PBS before microwave antigen retrieval
was applied. Sections were washed again in PBS, treated with
0.5% (v/v) hydrogen peroxide for 10 min, and incubated
with primary antibodies overnight at 4 C before being washed
and incubated with horseradish-conjugated secondary anti-
bodies (ABC kit; Vector Laboratories Inc., Burlingame, CA, USA).
The signal was developed using diaminobenzidine (DAB)
(Vector Laboratories) and nuclei were counterstained with
hematoxylin.
2.2.3. Scanning electron microscopy (SEM)
The scaffolds were ﬁxed with 2.5% (v/v) glutaraldehyde buffered
with PBS, dehydrated using a graded series of ethanol washes, and
dried to a critical point (EM CPD300; Leica, Wetzlar, Germany)
using carbon dioxide (CO2). Samples were sputter coated with gold
prior to SEM observation. The pore size and microstructure of the
scaffolds were observed using SEM (S-4800 ﬁeld emission scanning
electronmicroscope; Hitachi, Tokyo, Japan), and themean pore size
is calculated through SEM.
2.2.4. Water absorption and porosity
Water absorption of the scaffolds was measured as follows: Dry
scaffolds were weighed (W0) then immersed in PBS buffer at room
temperature overnight to allow free liquid absorption. The wet
scaffolds were removed and weighed (W1) and the percentage
water absorption was calculated according to the following
equation:%Water absorption ¼ ½ðW1 W0Þ=W0  100%
The porosity of the scaffolds was measured as follows: the
volumes of ethanol vials were measured (V1), scaffolds were placed
in the vials for 10 min and the volumes were measured (V2).
Scaffolds were then removed and the volume of the remaining
ethanol measured (V3). This procedure was repeated ﬁve times and
the mean values were used to calculate the porosity of the scaffolds
according to the following equation:
Porosity ¼ ½ðV1  V3Þ=ðV2  V3Þ  100%
2.2.5. Mechanical testing
Scaffold specimens of different sizes were prepared for me-
chanical testing. For unconﬁned compressive strength,
5  5  5 mm cubes of each scaffold were tested using a BOSE
biomechanical testing machine (BOSE 5100; TE Instruments, New
Castle, DE, USA). For tensile strength, 2  5  10 mm specimens
were tested using a uniaxial materials testing machine (model
5969; Instron, High Wycombe, UK). All specimens were kept moist
using PBS throughout these tests.
2.3. In vitro cytocompatibility studies
2.3.1. Rabbit meniscus ﬁbrochondrocyte isolation and culture
Rabbit meniscal ﬁbrochondrocytes were isolated as follows:
Menisci were dissected from rabbit knees and sliced into
1  1  1 mm prills. These were digested for 2 h on a magnetic
stirrer using collagenase, with 100 lg/mL penicillin and 100 lg/mL
streptomycin, in Dulbecco's modiﬁed Eagle's medium (DMEM)
(Corning, Glendale, AZ, USA). The cells were isolated by centrifu-
gation (1500 rpm for 5 min) and cultured in DMEM with 10% FBS
(Sigma-Aldrich) in 75 cm2 ﬁasks (BD Bioscience, San Jose, CA,
USA). After 90% conﬁuence was reached, the cells were diluted
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compatibility studies.
2.3.2. Cell seeding on scaffolds
Before seeding with cells, scaffolds were cut into discs (2 mm
thick, 5 mm in diameter); they were then sterilized, washed in
sterile PBS, and treated with DMEM (Corning) overnight. Each
scaffold was seeded with 1  106 ﬁbrochondrocytes in 100 mL
medium (DMEM þ 10% FBS). Cells were allowed to adhere for 2 h;
then, more media was added and this was changed every 2 d over
the following 2 weeks.
2.3.3. Scanning electron microscopy
We utilize the SEM to observe the microstructure of the cell-
scaffold composites and the growth of ﬁbrochondrocytes cultured
in vitro on the scaffolds. Cell-scaffold composites were acquired for
3 d after seeding the cells. Samples were ﬁxed in 2.5% (v/v)
glutaraldehyde, buffered with PBS and treated as described above.
After coating with gold, cell-scaffold composites were observed
using an S-4800 ﬁeld emission SEM (Hitachi).
2.3.4. Cell viability staining
To evaluate the cytotoxicity of the three different types of
scaffold using ﬁbrochondrocytes, cell viability was observed with a
Live/Dead Assay kit (Invitrogen) after cells were seeded and
cultured for 3 days. The cell/scaffold constructs were washed with
sterile PBS (3  5 min) and incubated in PBS solution with 2 mM
calcein AM and 4 mM ethidium homodimer-1 for 1 h at room
temperature. After another wash with sterile PBS, constructs were
observed using a Leica TCS-SP8 confocal microscope (Leica) and the
images analyzed with Imaris software (ver. 7.4.; Bitplane, Zurich,
Switzerland). Cell viability was calculated as follows: (live cells/
total cells)  100%.
2.3.5. Biochemical assays for DNA, GAG and collagen
After 3, 7 and 14 d of culture, the cell/scaffold constructs were
assayed for DNA, GAG and collagen. The TIANamp Genomic DNA kit
was used to extract DNA (TIANamp), and this was quantiﬁed using
the PicoGreen DNA assay kit (Invitrogen), all as described above.
For sGAG quantiﬁcation, the 1, 9-dimethylmethylene blue
(DMMB) assay and Tissue GAG Total Content DMMB Colorimetry kit
(GenMed) were used according to the manufacturer's instructions,
and as described above. The sGAG secreted by ﬁbrochondrocytes
were measured in two parts: the sGAG in cell/scaffold constructs
and the sGAG in the media. For quantiﬁcation of collagen, the hy-
droxyproline assay kit was used according to the manufacturer's
protocol (Nanjing Jiancheng). Collagen was also measured in two
parts: collagen in cell/scaffold constructs and collagen in themedia.
2.4. In vivo animal studies
2.4.1. Surgical procedure
This study was performed under a protocol approved by the
Institutional Animal Care and Use Committee at PLA General Hos-
pital. In total, 32 3-month old New Zealand white rabbits were
randomly allocated into four groups of 8 rabbits as follows: a
control group with meniscectomy only and no graft implant; an
AEMCM group with meniscectomy and AMECM scaffold implant; a
DCB group with meniscectomy and DCM scaffold implant; and an
AEMCM/DCB group with meniscectomy and AMECM/DCB scaffold
implant. Under anesthetic with intramuscular injections of 160 mg
ketamine and 12 mg xylazine, the medial collateral ligament was
cut down to expose the posterior horn of the medial meniscus.
Meniscectomy was performed in both stiﬂe joints of all rabbits and
the test groups were implanted with the appropriate scaffolds. Thecontrol group were not implanted. The implants were sutured to
the capsule at the level of the original meniscal rim, and the
anterior and posterior horns were ﬁxed to the meniscal ligaments.
The capsule was then closed and the medial collateral ligament
reconstructed using resorbable sutures. After the operation, each
rabbit was given intramuscular penicillin injections to prevent
infection, and returned to its cage where it was free to move. All
rabbits were euthanized and evaluated at the appropriate time
point (3 or 6 months).
2.4.2. Macroscopic observations
The tibial plateau with the meniscus and the femoral condyles
were observed and photographed [22,23].
2.4.3. Histological and immunohistochemical analyses
The regenerated meniscal tissue was ﬁxed in 4% para-
formaldehyde for 3 days, and embedded in parafﬁn. The corre-
sponding distal femur and proximal tibia were decalciﬁed in 10%
EDTA solution for 28 days after being ﬁxed in 4% paraformaldehyde
for 3 days, and then also embedded in parafﬁn. The regenerated
meniscus and bone-cartilage were sectioned into 7 mm slices and
stained with H&E, toluidine blue, safranin-O and Sirius Red.
Meniscal regeneration was evaluated quantitatively using the Ish-
ida score [24]. Cartilage degeneration of the femoral condyle and
tibial plateau were evaluated using the Mankin score [25]. The
nativemeniscus and articular cartilage derived fromhealthy rabbits
were compared as a control.
2.4.4. Magnetic resonance imaging (MRI)
The MRI scans were performed using a 7.0 T Bruker Biospec
system (Bruker, Ettlingen, Germany). The rabbit knee joints were
positioned straight (i.e., not ﬂexed) in an MRI-compatible device. A
small animal-speciﬁc knee coil was used as the transmitter coil and
a separate quadrature surface coil (Bruker) was placed above the
knee joint to achieve maximal signal reception. T2-weighted im-
aging (T2WI) was performed (repetition time ¼ 3200 ms/echo
time ¼ 65 ms; slices ¼ 15, slice thickness ¼ 1 mm, replicate
measurements ¼ 3). In addition to the experimental and control
groups, healthy rabbit knee MRI scans were also conducted as a
positive control.
2.4.5. RT-PCR
Total RNA was extracted from the regenerated menisci using a
standard Trizol procedure (Invitrogen), and the concentration and
purity of the RNA was checked with a NanoDrop ND-2000 Spec-
trophotometer (Thermo Fisher, Wilmington, MA, USA). To ensure
the purity of the RNA, only samples with an absorbance 260/
280 nm ratio of >1.8 were analyzed. The mRNA were reverse-
transcribed into cDNA using a ReverTra Ace kit (Toyobo, Osaka,
Japan). Reactions were conducted at 95 C for 10 min, followed by
40 cycles of 95 C for 15s, 58 C for 15s, 72 C for 35s, and ﬁnally
60 C for 1 min. Gene expression of aggrecan, SOX9 and collagen
types I and II were quantiﬁed using real-time PCR on a LightCycler
480 system (Roche Applied Science, Indianapolis, IN, USA). Target
genes were ampliﬁed using speciﬁc primers: aggrecan (XM_002-
723376.1, forward: 50-GGAGGAGCAGGAGTTTGTCAA-30 and reverse:
50-TGTCCATCCGACCAGCGAAA-30), SOX9 (XM_002719499, forward:
50-GCGGAGGAAGTCGGTGAAGAAT-30 and reverse: 50-AAGATGGC-
GTTGGGCGAGAT-30), collagen I (NM_001195668.1, forward: 50-
GCCACCTGCCAGTCTTTACA-30 and reverse: 50-CCATCATCACCATCT-
CTGCCT-30), and collagen II (XM_002723438.1, forward: 50-
CACGCTCAAGTCCCTCAACA-30, and reverse: 50-TCTATCCAGTAGT-
CACCGCTCT-30). The house-keeping gene, glyceraldehyde-3-
phosphatedehydrogenase (GAPDH), was used as a reference gene
(NM_001082253.1, forward: 50-CAAGAAGGTGGTGAAGCAGG-30 and
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aggrecan, SOX9, collagen I and collagen II were all normalized to the
value of GAPDH at the corresponding time points.
2.4.6. Tensile strength test
To test tensile strength, regenerated menisci frommonths 3 and
6 were cut into tubular sections (2  3  10 mm) along the long
axis. The sections were tested using a materials testing machine
(model 5969, Instron). Sections were preloaded to 0.5 N, pre-
conditioned from 0% to 2% strain for 15 cycles, and tension was
increased at a rate of 0.5% per second. The tensile modulus was
determined by the stress-strain curve.
2.5. Statistical analysis
Statistical analysis was performed with one-way analysis of
variance (ANOVA) using PASW for Windows software (ver. 18.0;
SPSS Inc., Chicago, IL, USA). All data were expressed as
means ± standard deviation (SD), and overall signiﬁcancewas set at
p < 0.05.
3. Results
3.1. Physicochemical and biological characteristics of the scaffolds
3.1.1. Scaffold microstructure
A macroscopic photograph of the three different types of scaf-
fold is shown in Fig. 2A, and SEM images in Fig. 2D show circular
pores in the size range of 192.6 ± 11.5 mm for the AMECM scaffold,
316.5 ± 40.4 mm for the DCB scaffold and 122.0 ± 26.6 mm for the
AMECM/DCB scaffold (Table 1). The porosity of each scaffold was
also measured: 90.54 ± 0.71% (n ¼ 5) for the AMECM scaffold,
95.05 ± 0.86% (n¼ 5) for the DCB scaffold and 90.60 ± 1.49% (n¼ 5)
for the AMECM/DCB scaffold (Table 1). In addition, percentage
water absorption was recorded: 3151.23 ± 68.15% for the AMECM
scaffold, 956.56 ± 95.34% for the DCB scaffold and 1431.78 ± 56.49%
for the AMECM/DCB scaffold (Table 1).
Hoechst 33258 staining demonstrated that there were no re-
sidual nuclei in any of the three scaffold types (Fig. 2B), and this was
conﬁrmed by residual DNA quantiﬁcation in all three scaffold types.
The residual DNA concentration was less than 20 pg/mg (Fig. 2C),
indicating that most cells were removed after decellularization.
3.1.2. Histological staining and biochemical analysis
The three different types of scaffold were analyzed by histo-
logical staining and biochemical analysis. Toluidine blue and
safranin-O staining were positive in the AMECM and AMECM/DCB
scaffolds, but negative in the DCB scaffold (Fig. 2E). A positive result
with these stains indicates that GAG content derived from the
meniscal ECM remains after decellularization. Sirius red staining
(Fig. 2E) shows abundant type I collagen as red or yellow ﬁbers in
all three scaffolds. A small amount of type II collagen appears, but is
only loosely held-together, in the AMECM and AMECM/DCB scaf-
folds, while no type II collagen is seen at all in the DCB scaffold. This
result was conﬁrmed by immunohistochemical analysis for
collagen type I and type II in the three scaffold types (Fig. 2E). The
biochemical analysis of total GAG and collagen in the three different
scaffolds is shown in Fig. 2F and G, and this is consistent with the
histological result. The GAG content in the AMECM and AMECM/
DCB scaffolds was higher than in the DCB scaffold (p < 0.05), but
there was no signiﬁcant difference in collagen content among the
three different scaffold types.
3.1.3. Mechanical characterization
To evaluate biomechanical properties, compressive and tensilestrength testing was used to compare the three different scaffolds.
The compressive modulus was approximately 2.44 ± 0.78 kPa for
the AMECM scaffold, 25.85 ± 3.92 kPa for the DCB scaffold and
86.34 ± 8.65 kPa for the AMECM/DCB scaffold (Fig. 2H). The tensile
modulus was approximately 0.24 ± 0.16 kPa for the AMECM scaf-
fold, 9.57 ± 3.11 kPa for the DCB scaffold and 19.09 ± 2.38 kPa for
the AMECM/DCB scaffold (Fig. 2F). Therefore, the AMECM/DCB
scaffold is clearly stronger (both in terms of compressive and ten-
sile strength) than the AMECM and DCB scaffolds.
3.2. Cytocompatibility analysis of scaffolds using meniscus
ﬁbrochondrocytes
3.2.1. Fibrochondrocyte attachment and viability on the scaffolds
The attachment of ﬁbrochondrocytes to the three different
scaffolds was observed using SEM (Fig. 3A). The ﬁbrochondrocytes
attached to all three scaffolds and migrated well between inter-
connecting pores in the AMECM and AMECM/DCB scaffolds over a
3-day culture period. Fibrochondrocytes were less well distributed
between interconnecting pores in the DCB scaffold after 3 days of
culture. This is probably because pore size in the DCB scaffold was
greater than in the AMECM and AMECM/DCB scaffolds, making
strong attachment to the interconnecting pores more difﬁcult.
Fibrochondrocyte viability on the three different scaffolds was
evaluated by live/dead cell staining after 3 days of culture. For the
AMECM and AMECM/DCB scaffolds, most cells were stained ﬂuo-
rescent green (living cells), with very few red (dead) cells. Most
cells were also alive on the DCB scaffold; however, the proportion of
dead cells increased. The quantitative cell viability analysis (n ¼ 5)
suggested that cell viability on the AMECM and AMECM/DCB
scaffolds may be higher than on the DCB scaffold, but did not
demonstrate any signiﬁcant differences (Fig. 3B).
3.2.2. Biochemical analysis
Quantiﬁcation of DNA, total GAG, and collagen was used to
measure the proliferation of ﬁbrochondrocytes and ECM deposi-
tion. DNA content measurements suggested that ﬁbrochondrocytes
increased by approximately 37%, 28%, and 36% at 7 days and by
approximately 91%, 78%, and 89% at 14 days compared with the
number of cells at 3 days, for the AMECM, DCB, and AMECM/DCB
scaffolds, respectively (Fig. 3C1).
Both sGAG and collagen content increased over time in each of
the three scaffolds (p 0.01) (day 14 vs. day 7; day 7 vs. day 3). Total
sGAG content (scaffold þ media) increased by approximately 70%,
62%, and 79% at 7 days and by approximately 233%, 210%, and 251%
at 14 days compared with sGAG secreted by the ﬁbrochondrocytes
at 3 days, for the AMECM, DCB, and AMECM/DCB scaffolds,
respectively (Fig. 3C2). To evaluate the sGAG secreted by ﬁbro-
chondrocytes, we calculated sGAG normalized for DNA content.
This increased over time, as measured at days 3, 7, and 14 (p 0.01)
(Fig. 3C3). sGAG deposition in the AMECM and AMECM/DCB scaf-
folds was higher than in the DCB scaffold for 7 and 14 day-old
cultures, and this was conﬁrmed by normalized sGAG per DNA
content analysis. Therefore, the AMECM and AMECM/DCB scaffolds
can promote ﬁbrochondrocyte proliferation and sGAG synthesis.
As collagen can also be secreted into the medium while ﬁbro-
chondrocytes are being cultured, total collagen was estimated both
as that present in the media and that deposited in the scaffolds.
Total collagen from the ﬁbrochondrocytes increased by approxi-
mately 80%, 57%, and 85% at 7 days and by approximately 218%,
181%, and 237% at 14 days compared with collagen secreted by
ﬁbrochondrocytes at 3 days, for the AMECM, DCB, and AMECM/DCB
scaffolds, respectively (Fig. 3C4). Similarly, total collagen normal-
ized for DNA content in the AMECM and AMECM/DCB scaffolds was
signiﬁcantly higher than in the DCB scaffold at 7 days and 14 days
Fig. 2. The physicochemical and histological properties of the three different scaffolds. A, Macroscopic features of the three different scaffolds. B, Hoechst staining of the three
different scaffolds. C, Residual DNA quantitative analysis of the three different scaffolds; values are presented as means ± standard deviation (n ¼ 5). D, Scanning electron mi-
crographs of the three different scaffolds. E, Histological analysis of the three different scaffolds and native meniscus; sections from the three different scaffolds and native meniscus
stained with toluidine blue (B), Safranin-O (SO), Sirius Red, and immunohistochemical analysis for type I collagen (Col 1) and type II collagen (Col 2). F, Glycosaminoglycan (GAG)
content of the three different scaffolds; values are presented as means ± standard deviation (n ¼ 5; *p < 0.05 and **p < 0.01). G, Total collagen content of the three different scaffolds
and native meniscus (n ¼ 5). H, Comparative graph showing the compressive modulus of the three different scaffolds; data are expressed as means ± standard deviation (n ¼ 5;
**p < 0.01). I, Comparative graph showing tensile modulus of the three different scaffolds; data are expressed as means ± standard deviation (n ¼ 5; **p < 0.01).
Table 1
Comparison of the pore size, porosity and water absorption of the three scaffolds.
AMECM DCB AMECM/DCBS
Pore size (mm) 192.6 ± 11.5 316.5 ± 40.4 122.0 ± 26.6 (*)
Porosity (%) 90.54 ± 0.71 95.05 ± 0.86 90.60 ± 1.49 (*)
Water absorption (%) 3151.23 ± 68.15 956.56 ± 95.34 1431.78 ± 56.49 (*)
AMECM, acellular meniscus extracellular matrix; DCB, demineralized cancellous
bone.
(n ¼ 5, *p < 0.05).
Z. Yuan et al. / Biomaterials 111 (2016) 13e26 19respectively (Fig. 3C5). All data indicate that the AMECM and
AMECM/DCB scaffolds can promote the secretion of collagen by
ﬁbrochondrocytes.
3.3. The AMECM/DCB scaffold promoted meniscus regeneration
To compare their effect onmeniscus regeneration, we implanted
the AMECM, DCB and AMECM/DCB scaffolds in rabbits that had
undergone total meniscectomy (Fig. 4A). Macroscopically, the
control and AMECM groups displayed no obvious meniscal tissue
regeneration, and the corresponding tibial plateau and femoral
condyle cartilage showed signiﬁcant damage at 3 and 6 months
post-operation. In contrast, the DCB and AMECM/DCB groups did
have regenerated meniscal tissue and the corresponding cartilage
was not as seriously damaged as it was in the control and AMECM
groups. Additionally, we found that meniscus regenerated in the
AMECM/DCB group was more similar to native meniscus than that
of the DCB group, and that regenerated meniscus in the AMECM/
DCB group was the most similar of all, in terms of appearance, to
native meniscus at 6 months post-operation (Fig. 4B). As there is no
obvious neomeniscus emerge in AMECM and control group, the
relevant testing could not be performed.
Histological H&E staining of the DCB group neomenisci 3
months after surgery (Fig. 5A) demonstrated the appearance of
abundant elongated ﬁbroblast-like cells, while no chondrocyte-like
cells were apparent. Toluidine blue staining was negative. Collagen
I immunohistochemical staining was positive, while collagen II
staining was negative. Picrosirius Red staining also highlighted a
tangled arrangement of collagen ﬁbers. H&E staining of the DCB
group neomenisci 6 months after surgery shows the appearance of
small, rounded chondrocyte-like cells. Toluidine blue staining is
weakly positive; Collagen I immunohistochemical staining is pos-
itive, while collagen II staining is weakly positive. Picrosirius red
staining still shows that the arrangement of collagen ﬁbers is
disordered.
Histological H&E staining of the AMECM/DCB group neomenisci
3 months after surgery showed small chondrocyte-like cells
emerging. Toluidine blue staining is weakly positive; collagen I
immunohistochemical staining is positive, while collagen II stain-
ing is weakly positive. Picrosirius red staining shows a disordered
arrangement of collagen ﬁbers. In contrast, H&E staining of the
AMECM/DCB group neomenisci 6 months after surgery shows
abundant chondrocyte-like cells and cartilage lacuna emerging.
Toluidine blue staining is strongly positive. Collagen I immuno-
histochemical staining is positive, collagen II staining is also posi-
tive. Picrosirius red staining now shows a well-organized
arrangement of collagen.
We also examined one 3-month old healthy rabbit as a control.
This comparison indicated that the histological characteristics of
neomeniscus in the AMECM/DCB group at 6 months is the most
similar to native meniscus.
Histological scores for regenerated menisci in the AMECM/DCB
group were better than those in the DCB group at 3 and 6 months
(Fig. 5C).
3.4. Menisci regenerated using the scaffolds prevented cartilage
degeneration
Next, we evaluated the chondroprotective effect of regenerated
meniscus by histological examination (toluidine blue) of the cor-
responding femoral condyle and tibial plateau cartilage (Fig. 5B).
Histological examination yielded results similar to the macroscopic
ﬁndings. Cartilage degeneration progressed in the control and
AMECM group over 6 months, whereas it was better preserved in
the DCB and AMECM/DCB groups, with cartilage in the AMECM/DCB group being the best preserved over the 6 month period.
Mankin scores for both the femoral condyle (Fig. 5D) and tibial
plateau (Fig. 5E) cartilage in the AMECM/DCB group at 3 and 6
months were signiﬁcantly better than those of the other three
groups.
3.5. MRI assessment of rabbit knees after scaffold implants
We evaluated the degeneration of rabbit knee joints MRI. MRI
evaluation (Fig. 6A), showed massive inﬂammatory signals
emerging from the knee joints of the control and AMECM groups,
weak inﬂammatory signals in the DCB group, and no obvious in-
ﬂammatory signals in the AMECM/DCB group. While there were
clear signals indicating the appearance of meniscus-like tissue in
the meniscus triangle region of the coronal and sagittal projection
in the AMECM/DCB and DCB groups, only inﬂammatory signals
were observed in the meniscus triangle region of the control and
AMECM groups. When semi-quantitative Whole-Organ Magnetic
Resonance Imaging Scores (WORMS) [26]were used to grade the
different groups, the AMECM/DCB group knees were signiﬁcantly
healthier than those of the other three groups (Fig. 6B).
3.6. The regenerated meniscus restored biomechanical properties
and gene expression
All rabbits that underwent operations resumed weight bearing
and locomotion after surgery. Gene expression in the regenerating
menisci was shown to vary. Aggrecan, SOX9, and collagen II gene
expression levels increased in regenerating menisci over 6 months
in the DCB and AMECM/DCB groups, whereas for collagen I the
increase in expression level was not statistically signiﬁcant. The
aggrecan, SOX9, and collagen II expression levels in regenerated
menisci from the AMECM/DCB groupwere signiﬁcantly higher than
in the DCB group at 3 and 6 months (Fig. 7A).
The tensile modulus of regenerated meniscus increased over 6
months in the DCB and AMECM/DCB groups, and was signiﬁcantly
higher in the AMECM/DCB group than in the DCB group at 3 and 6
months. The tensile modulus of regenerated meniscus in the
AMECM/DCB group at 6months is similar to that of nativemeniscus
(Fig. 7B).
4. Discussion
In this study, we used natural meniscus ECM and DCB as scaf-
folds for meniscus engineering. The ECM provides the necessary
microenvironment to regulate cell behaviors, including cell
migration and matrix synthesis [16]. The DCB have natural 3D pore
structure, good biocompatibility, especially, the well mechanical
strength. And both the in vitro and in vivo study conﬁrm that the
AMECM/DCB combination is greater than either on its own.
Compare to polymers materials, which have been widely used in
meniscus regeneration due to their biodegradability and biome-
chanical properties [27,28], the AMECM/DCB scaffold has the better
biocompatibility and can preferably facilitate cell proliferation and
Fig. 3. Cytocompatibility analysis of the three different scaffolds. A, Scanning electron micrographs of the three different scaffolds on which rabbit ﬁbrochondrocytes were seeded
for 3 days. B, Live/dead cell analysis for the three different scaffolds on which rabbit ﬁbrochondrocytes were seeded for 3 days; representative images show dead (red) cells, live
(green) cells and 3D reconstruction images of the ﬁbrochondrocyte distribution in the three different scaffolds, and the viability analysis for the ﬁbrochondrocytes on the three
different scaffolds. C, Biochemical assay results showing: (C1) DNA content; (C2) total GAG content; (C3) GAG/DNA; (C4) total collagen; (C5) collagen/DNA, estimated in three scaffolds
individually seeded with ﬁbrochondrocytes after days 3, 7 and 14. Data are expressed as means ± standard deviation (n ¼ 4; *p < 0.05, **p < 0.01).
Fig. 4. Macroscopic analyses of regenerated menisci and the corresponding femoral condyles. A, Surgical strategy and study schema. B, Macroscopic observations; red dashed line
indicates regenerated meniscus; black dashed line indicates native meniscus.
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complete meniscus repair process in vivo as both meniscus ECM
and DCB are easily degraded, and the degradation products may
themselves be used for meniscus reconstruction by meniscus cells,
while the polymer degradation may interfere with meniscus
regeneration [29]. Compare to other collagenic meniscus scaffolds,
such as CMI, derived from puriﬁed type I collagen of bovine Achilles
tendon, the AMECM/DCB scaffold may provide the better micro-
bioenvironment, which contain the meniscus original “soil”,
meniscus ECM.The in vitro experiments found that the AMECM/DCB composite
scaffold had better biomechanical properties than the AMECM or
DCB scaffolds. This may be because the AMECM scaffold consists of
thin collagen ﬁbers and glycosaminoglycan particles (analogous to
a concrete ﬁller), and the DCB scaffold consists of bulky ﬁbers
(similar to a bar framework), so that the AMECM/DCB scaffold can
be regarded as analogous to reinforced concrete, greatly enhancing
its biomechanical properties. Fibrochondrocytes grow well on all
three types of meniscus scaffold. Both the AMECM and AMECM/
DCB scaffolds promote ﬁbrochondrocyte proliferation and
Fig. 5. Histological analyses of regenerated menisci and corresponding cartilage. A, Neomeniscus sections stained with H&E, TB, Picrosirius Red (PR), and immunostained for Col I
and Col II. One 3 month old healthy rabbit was used as a control. B, Sagittal sections from the medial femoral condyle cartilage and medial tibial plateau cartilage of rabbits from
each group, stained with toluidine blue 3 months and 6 months after surgery. One 3 month old normal rabbit was used as a control. C, Ishida histological score for regenerated
meniscus. D, Mankin scores for medial femoral condyle cartilage. E, Mankin scores for medial tibial plateau cartilage. Data are expressed as mean ± standard deviation (n ¼ 3;
*p < 0.05).
Fig. 6. Magnetic Resonance Imaging (MRI) scans. A, MRI of rabbit knees 3 months and 6 months after surgery. The left panels show coronal scanning and the right panels show
sagittal scanning. One 3 month old healthy rabbit was used as a control. The white arrow indicates synovial ﬂuid effusion, The red arrow indicates the regenerated menisci. B, The
Whole-Organ Magnetic Resonance Imaging Score (WORMS) for MRI. Data are expressed as means ± standard deviation (n ¼ 8; *p < 0.05, **p < 0.01).
Z. Yuan et al. / Biomaterials 111 (2016) 13e26 23secretion of sGAG and collagen better than the DCB scaffold. This
may be because both the AMECM and AMECM/DCB scaffolds
consist of meniscus ECM molecules that play essential roles in
regulating cell behaviors, including cell migration, proliferation and
differentiation.
The in vivo study found regenerated meniscus appearing
macroscopically in the AMECM/DCB and DCB groups but not in
AMECM group. This may be because the poor biomechanical
properties of the AMECM scaffold made it hard to secure during the
operations and it was subsequently degraded too easily. After 6
months, the regenerated menisci of the AMECM/DCB group were
histologically more similar to native menisci than those of the DCB
group. Toluidine blue and type II collagen staining was more
extensive in regenerated menisci of the AMECM/DCB group, and
histological scores for neomenisci of the AMECM/DCB group were
better than those of the DCB group. These ﬁndings indicate theefﬁcacy of the AMECM/DCB scaffold in promoting meniscus
regeneration. A histological evaluation of cartilage from the femoral
condyle and tibial plateau also demonstrates that regenerated
menisci from the AMECM/DCB group are more effective in pre-
venting cartilage degeneration and the progress of osteoarthritis
than those from the DCB group, a ﬁnding that is conﬁrmed by MRI
scans. It was discovered that the biomechanical properties and
gene expression characteristics of regenerated menisci in the
AMECM/DCB and DCB groups were more similar to those of native
menisci at 6 months than they were at 3 months, and that regen-
erated menisci from the AMECM/DCB group were more similar
than those of the DCB group to native menisci. Therefore, regen-
eration of menisci with the necessary functional properties and
tissue characteristics can be orchestrated by the AMECM/DCB
scaffold, which provides an enhanced protective effect on the
articular surfaces compared with the other scaffolds tested.
Fig. 7. Gene expression levels and tensile modulus of the neomeniscus. A, Real-time gene expression results showing fold increases in aggrecan, SOX9, collagen I, and collagen II
gene expression in neomenisci of different groups 3 and 6 months after surgery. One native rabbit was used as a control. B, The tensile modulus of neomenisci in different groups 3
and 6 months after surgery. The 6-month-old and 9-month-old native rabbits were used as control respectively. Data are expressed as means ± standard deviation (n ¼ 3; *p < 0.05,
**p < 0.01).
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ment, there are still some limitations in this study. Here, in order to
make the paper more rigorous as well as make our research more
perfect in the future, we listed the limitations in the following. A
drawback of the animal model, rabbits especially 3-month-old
rabbits, is its more tendency to regeneration than the large animal
models, such as the sheep model, which would be used in our next
experiment. Another limitation is the undone compression testing
for the neomeniscus in the in-vivo study. Although there are some
limitations in this paper, the study still can conﬁrm that the
AMECM/DCB scaffold can better promotes meniscus regeneration
and prevents cartilage degeneration in a rabbit meniscus defect
model compared with the other scaffolds tested.
In contrast to cell transplantation, the present strategy serves as
a therapeutic prototype for meniscus regeneration and does not
require cell seeding [30]. The bioactive scaffold recruits endoge-
nous cells and provides an appropriate cartilage-inducing micro-
environment for cell proliferation and differentiation [31]. The
present study shows that an AMECM/DCB acellular biomaterial
scaffold can prompt successful total meniscus regeneration in a
rabbit total meniscectomy model by recruiting endogenous cells.The source of endogenous cells is unclear but may include the
synovium and vascular stem cells. Other studies have also indicated
the extensive involvement of endogenous cells in meniscus
regeneration. Ozeki and co-workers [23] transplanted Achilles
tendons from wild-type rats into meniscal defects in LacZ-
transgenic rat knees. The transplanted tissue was subsequently
covered by LacZ-transgenic rat synovium, indicating that synovial
coverage by the host knee joint plays an important role in sup-
porting meniscus remodeling and regeneration. Researchers from
Chang Lee's laboratory [7] used a 3D-printed meniscus scaffold and
spatiotemporal release of CTGF and TGFb3 without cell seeding to
prompt meniscus regeneration in a sheep partial meniscectomy
model, also indicating that endogenous cells can be recruited for
meniscus regeneration. Merriam and co-workers [8] implanted a
novel ﬁber-reinforced meniscus scaffold in an ovine total menis-
cectomy model, and demonstrated that the scaffold could suc-
cessfully induce the formation of neomeniscus tissue that remained
intact and functional, also without the need for cell seeding. These
ﬁndings suggest that cell inﬁltration can play a crucial role in tissue
engineering meniscus regeneration and can produce the appro-
priate proteins and structure in their native locations.
Fig. 8. Mechanism of meniscus regeneration. Meniscus scaffolds, host knee synovial tissue and endogenous stem cells contributed to meniscus regeneration in these experiments.
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eration in this study (Fig. 8). When meniscus defects were not
treated (control group) or treated using the AMECM scaffold, only a
small amount of synovial tissue proliferation was observed in situ
and this had no effect on preventing cartilage degeneration.
Because the DCB scaffold has good biomechanical properties and
can be ﬁxed in situ to the rabbit knee, meniscus defects treatedwith
DCB scaffold synovial tissue and other endogenous cells supported
neomeniscus tissue formation and prevented cartilage degenera-
tion and the progression of osteoarthritis. The AMECM/DCB scaffold
has even better biomechanical characteristics and ECM protein
molecules can stimulate cell behaviors, including cell proliferation,
migration, and differentiation that enhance the capacity of the
AMECM/DCB scaffold to promote neomeniscus formation and
prevent cartilage degeneration and the progress of osteoarthritis.
5. Conclusion
The AMECM/DCB scaffold has good biocompatibility and
biomechanical characteristics. It promotes ﬁbrochondrocyte pro-
liferation and the secretion of collagen and glycosaminoglycan. It
also promotes meniscus regeneration and prevents cartilage
degeneration in a rabbit meniscus defect model.
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